Ninan Jacob, Nikravangolsefid Nasrin, Truong Hong Hieu, Charkviani Mariam, Prokop Larry J, Murugan Raghavan, Clermont Gilles, Kashani Kianoush B, Domecq Garces Juan Pablo
Department of Nephrology and Critical Care Medicine, MultiCare Capital Medical Center, Olympia, WA, USA.
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
J Nephrol. 2025 May 3. doi: 10.1007/s40620-025-02288-4.
Intradialytic hypotension is associated with increased morbidity, and mortality. Several machine learning (ML) algorithms have been recently developed to predict intradialytic hypotension. We systematically reviewed ML models employed to predict intradialytic hypotension, their performance, methodological integrity, and clinical applicability.
We conducted this systematic review with a pre-established protocol registered at the International Prospective Register of Systematic Reviews (PROSPERO ID: CRD42022362194). Six databases, from their inception to July 20, 2023, were comprehensively searched. Two independent investigators reviewed the articles, extracted data, and evaluated the risk of bias using the Prediction model Risk of Bias Assessment Tool (PROBAST).
Out of 84 screened articles, 16 studies with 14,500 adult patients on hemodialysis were included in the review. Fourteen studies (87.5%) were found to have a high risk of bias. The intradialytic hypotension prevalence in the population investigated was between 1.2 and 51%. A diverse range of predictive ML tools were used to predict intradialytic hypotension, with various neural networking models being the most frequent, appearing in 13 studies (AUROC ranges: 0.684-0.978). One study performed both internal and external validation.
Researchers have made a concerted effort to develop ML tools to predict intradialytic hypotension. Despite their significant efforts, the lack of thorough external and clinical validation, and heterogeneity among the models and settings have resulted in a substantial challenge to offering ML tools as a global intradialytic hypotension prevention and management solution. Future studies should focus on external and clinical validation of these models to enhance the chances of clinically relevant changes in clinical practices.
透析中低血压与发病率和死亡率的增加相关。最近已开发出几种机器学习(ML)算法来预测透析中低血压。我们系统地回顾了用于预测透析中低血压的ML模型、它们的性能、方法的完整性和临床适用性。
我们按照在国际前瞻性系统评价注册库(PROSPERO编号:CRD42022362194)注册的预先制定的方案进行了这项系统评价。全面检索了六个数据库,检索时间从其创建到2023年7月20日。两名独立研究人员对文章进行了审查、提取数据,并使用预测模型偏倚风险评估工具(PROBAST)评估偏倚风险。
在84篇筛选的文章中,有16项研究纳入了14,500名接受血液透析的成年患者。发现14项研究(87.5%)存在高偏倚风险。所调查人群中的透析中低血压患病率在1.2%至51%之间。使用了各种预测性ML工具来预测透析中低血压,其中各种神经网络模型最为常见,出现在13项研究中(受试者工作特征曲线下面积范围:0.684 - 0.978)。一项研究进行了内部和外部验证。
研究人员齐心协力开发ML工具来预测透析中低血压。尽管付出了巨大努力,但缺乏全面的外部和临床验证,以及模型和设置之间的异质性,给将ML工具作为全球透析中低血压预防和管理解决方案带来了重大挑战。未来的研究应侧重于这些模型的外部和临床验证,以增加临床实践中出现临床相关变化的机会。